Počet záznamů: 1  

Novel Bradykinin Analogues Modified in the N-Terminal Part of the Molecule with a Variety of Acyl Substituents

  1. 1.
    SYSNO ASEP0377892
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevNovel Bradykinin Analogues Modified in the N-Terminal Part of the Molecule with a Variety of Acyl Substituents
    Tvůrce(i) Sleszynska, M. (PL)
    Wierzba, T. H. (PL)
    Malinowski, K. (PL)
    Tůmová, Tereza (UOCHB-X) RID
    Lammek, B. (PL)
    Slaninová, Jiřina (UOCHB-X)
    Prahl, A. (PL)
    Celkový počet autorů7
    Zdroj.dok.International Journal of Peptide Research and Therapeutics - ISSN 1573-3149
    Roč. 18, č. 2 (2012), s. 117-124
    Poč.str.8 s.
    Jazyk dok.eng - angličtina
    Země vyd.US - Spojené státy americké
    Klíč. slovabradykinin analogues ; B-2 receptor antagonists ; bulky acyl groups ; in vivo rat blood pressure test ; in vitro rat uterus test
    Vědní obor RIVCE - Biochemie
    CEZAV0Z40550506 - UOCHB-X (2005-2011)
    UT WOS000303453500004
    DOI10.1007/s10989-011-9285-5
    AnotaceIn the current work we present some pharmacological characteristics of ten new analogues of bradykinin (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) modified in the N-terminal part of the molecule with a variety of acyl substituents. Of the many acylating agents used previously with B-2 receptor antagonists, the following residues were chosen: 1-adamantaneacetic acid (Aaa), 1-adamantanecarboxylic acid (Aca), 4-tert-butylbenzoic acid (t-Bba), 4-aminobenzoic acid (Aba), 12-aminododecanoic acid (Adc), succinic acid (Sua), 4-hydroxybenzoic acid, 4-hydroxy-3-methoxybenzoic acid, 3-(4-hydroxyphenyl)propionic acid and 6-hydroxy-2-naphthoic acid. Biological activity of the compounds was assessed in the in vivo rat blood pressure test and the in vitro rat uterus test. Surprisingly, N-terminal substitution of the bradykinin peptide chain itself with aforementioned groups resulted in antagonists of bradykinin in the pressor test and suppressed agonistic potency in the uterotonic test. These interesting findings need further studies as they can be helpful for designing more potent B-2 receptor blockers.
    PracovištěÚstav organické chemie a biochemie
    Kontaktasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Rok sběru2013
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.